Oteracil, with the CAS number 937-13-3, is a chemical compound that belongs to the class of pyrimidine derivatives. It is primarily known for its role as a pharmaceutical agent, particularly in the context of cancer treatment. Oteracil functions as an inhibitor of the enzyme orotate phosphoribosyltransferase, which is involved in the synthesis of pyrimidine nucleotides. This inhibition can disrupt the proliferation of rapidly dividing cells, making it useful in chemotherapy regimens. The compound is typically administered in conjunction with other chemotherapeutic agents to enhance their efficacy while potentially reducing side effects. Oteracil is characterized by its specific molecular structure, which includes a pyrimidine ring, and it exhibits solubility in various solvents, making it suitable for formulation in different pharmaceutical preparations. As with many chemical substances, safety and handling precautions are essential, as it may pose risks if not managed properly. Overall, Oteracil represents an important tool in the arsenal against cancer, contributing to the development of targeted therapies.

Oteracil

937-13-3: 1,3,5-Triazine-2-carboxylic acid, 1,4,5,6-tetrahydro-4,6-dioxo-, 1,4,5,6-Tetrahydro-4,6-dioxo-1,3,5-triazine-2-carboxylic acid, 2,4-Dioxo-1,2,3,4-tetrahydro-1,3,5-triazine-6-carboxylic acid, 2,4-Dioxo-1,2,3,4-tetrahydro-1,3,5-triazine-6-carboxylicacid, 5-Azaorotic acid, Allantoxanic acid, Allantoxanicacid (6CI,7CI,8CI), Oteracil, Oxonic acid, s-Triazine-2,4-dione-6-carboxylic acid

Potassium Oxonate

Please enquire for more information about 4,6-Dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxylic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page

CAS 937-13-3: Oteracil

Potassium Oxonate

Ref: 3B-O0164

4,6-Dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxylic acid

Ref: 3D-AAA93713

Oteracil

Ref: TM-T68298

4,6-Dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxylic acid

Ref: IN-DA0061HS